EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer

Coraline Danieli, Cristiano S Moura, Louise Pilote, Sasha Bernatsky, Michal Abrahamowicz

Pharmacoepidemiology and Drug Safety · 2023

DOI: 10.1002/pds.5674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Coraline Danieli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Outcomes Research and Evaluation and Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Québec, Canada. Hauptthemen laut MEDLINE: Skin Neoplasms, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Network, Canadian Network for Advanced Interdisciplinary Methods for Comparative Effectiveness Research, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Hydrochlorothiazide (HCTZ), a widely prescribed antihypertensive drug with photosensitising properties, has been linked with non‐melanoma skin cancer (NMSC) risk. However, previous analyses did not fully explore if and how the impact of past HCTZ exposures accumulates with prolonged use and/or depends on time elapsed since exposures. Therefore, we used different models to more comprehensively assess how NMSC risk vary with HCTZ exposure, and explore how the results may depend on modeling strategies.

Methods

We used different parametric models with alternative time‐varying exposure metrics, and the flexible weighted cumulative exposure model (WCE) to estimate associations between HCTZ exposures and NMSC risk in a population‐based cohort of HCTZ users over 65 years old, in the province of Ontario, Canada.

Results

Among 3844 HCTZ users, 273 developed NMSC during up to 8 years of follow‐up. In parametric models, based on all exposures, increased duration of past HCTZ use was associated with an increase of NMSC risk but cumulative dose showed no systematic association. Yet, WCE results suggested that only exposures taken 2.5–4 years in the past were associated with the current NMSC hazard. This finding led us to re‐define the parametric models, which also confirmed that any HCTZ dose taken outside this time‐window were not systematically associated with NMSC incidence.

Conclusions

Our analyses illustrate how flexible modeling may yield new insights into complex temporal relationships between a time‐varying drug exposure and risks of adverse events. Duration and recency of antihypertensive agents exposures must be taken into account in evaluating risk and benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsHypertensionHumansAgedHydrochlorothiazideAntihypertensive AgentsIncidenceOntario

Stichwörter der Autor:innen

cumulative effectsflexible modelinglatencytime-varying exposureweighted cumulative exposure

Substanzen

HydrochlorothiazideAntihypertensive Agents

Autor:innen und Institutionen

  • Centre for Outcomes Research and Evaluation and Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Québec, Canada.
  • Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
  • Division of General Internal Medicine, McGill University Health Center, Montreal, Québec, Canada.
  • Division of Rheumatology, McGill University Health Center, Montreal, Québec, Canada.

Förderung

  • Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Network
  • Canadian Network for Advanced Interdisciplinary Methods for Comparative Effectiveness Research
  • Canadian Institutes of Health Research

Zitieren

APA

Danieli, C., Moura, C. S., Pilote, L., Bernatsky, S., & Abrahamowicz, M. (2023). Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5674

Vancouver

Danieli C, Moura CS, Pilote L, Bernatsky S, Abrahamowicz M. Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5674

BibTeX
@article{Danieli2023,
  author = {Danieli, Coraline and Moura, Cristiano S and Pilote, Louise and Bernatsky, Sasha and Abrahamowicz, Michal},
  title = {Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  doi = {10.1002/pds.5674}
}
Kostenlos starten →